113 related articles for article (PubMed ID: 8294212)
1. Prognostic significance of selected lifestyle factors in urinary bladder cancer.
Wakai K; Ohno Y; Obata K; Aoki K
Jpn J Cancer Res; 1993 Dec; 84(12):1223-9. PubMed ID: 8294212
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of urinary bladder cancer in metropolitan Nagoya.
Ohno Y; Aoki K; Obata K; Morrison AS
Natl Cancer Inst Monogr; 1985 Dec; 69():229-34. PubMed ID: 3834338
[TBL] [Abstract][Full Text] [Related]
3. Coffee, Tea, Cola, and Bladder Cancer Risk: Dose and Time Relationships.
Turati F; Bosetti C; Polesel J; Zucchetto A; Serraino D; Montella M; Libra M; Galfano A; La Vecchia C; Tavani A
Urology; 2015 Dec; 86(6):1179-84. PubMed ID: 26416008
[TBL] [Abstract][Full Text] [Related]
4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
5. Effects of dietary, drinking, and smoking habits on the prognosis of gastric cancer.
Huang XE; Tajima K; Hamajima N; Kodera Y; Yamamura Y; Xiang J; Tominaga S; Tokudome S
Nutr Cancer; 2000; 38(1):30-6. PubMed ID: 11341041
[TBL] [Abstract][Full Text] [Related]
6. Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.
Takaoka EI; Miyazaki J; Ishikawa H; Kawai K; Kimura T; Ishitsuka R; Kojima T; Kanuma R; Takizawa D; Okumura T; Sakurai H; Nishiyama H
Jpn J Clin Oncol; 2017 Jan; 47(1):67-73. PubMed ID: 27737963
[TBL] [Abstract][Full Text] [Related]
7. Bladder cancer: smoking, beverages and artificial sweeteners.
Morgan RW; Jain MG
Can Med Assoc J; 1974 Nov; 111(10):1067-70. PubMed ID: 4429932
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
9. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
11. Multivariate evaluation of prognostic determinants in bladder cancer patients.
Takashi M; Murase T; Mizuno S; Hamajima N; Ohno Y
Urol Int; 1987; 42(5):368-74. PubMed ID: 3433584
[TBL] [Abstract][Full Text] [Related]
12. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of microRNA-100 in patients with bladder cancer.
Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
[TBL] [Abstract][Full Text] [Related]
14. [Clinical prognostic factors in superficial cancer of the urinary bladder].
Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
[TBL] [Abstract][Full Text] [Related]
16. The relationship of local control to distant metastasis in muscle invasive bladder cancer.
Pollack A; Zagars GK; Cole CJ; Dinney CP; Swanson DA; Grossman HB
J Urol; 1995 Dec; 154(6):2059-63; discussion 2063-4. PubMed ID: 7500458
[TBL] [Abstract][Full Text] [Related]
17. Marital status and survival following bladder cancer.
Datta GD; Neville BA; Kawachi I; Datta NS; Earle CC
J Epidemiol Community Health; 2009 Oct; 63(10):807-13. PubMed ID: 19468015
[TBL] [Abstract][Full Text] [Related]
18. [Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy].
Takashi M; Murase T; Aota Y; Nagai T; Kinjo T; Sabashi M; Shimoji T; Miyake K; Hamajma N; Mizuno S
Hinyokika Kiyo; 1988 Aug; 34(8):1377-81. PubMed ID: 2461643
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
[TBL] [Abstract][Full Text] [Related]
20. Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
Scosyrev E; Wu G; Golijanin D; Messing E
Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
